Workflow
AMN Healthcare (AMN) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - AMN Healthcare Services reported a revenue of $687.51 million for the quarter ended September 2024, reflecting a year-over-year decline of 19.4% [1] - The earnings per share (EPS) for the quarter was $0.61, down from $1.97 in the same quarter last year, but exceeded the consensus estimate of $0.58 by 5.17% [1] - The reported revenue surpassed the Zacks Consensus Estimate of $670.08 million by 2.60% [1] Financial Performance Metrics - Physician and leadership solutions reported Days Filled of 55.32 million, slightly above the estimated 55.28 million [3] - Revenue per day filled for Physician and leadership solutions was $2.56 million, exceeding the average estimate of $2.48 million [3] - Revenue from Physician and leadership solutions was $180.61 million, surpassing the estimated $179.15 million, marking a year-over-year increase of 13.2% [3] - Revenue from Nurse and allied solutions was $399.37 million, which was above the estimated $383.11 million but represented a year-over-year decline of 30.4% [3] - Revenue from Technology and workforce solutions was $107.54 million, slightly below the estimated $107.67 million, with a year-over-year decline of 10.8% [3] - Segment operating income for Nurse and allied solutions was $35.11 million, below the average estimate of $39.43 million [3] - Segment operating income for Technology and workforce solutions was $41.95 million, slightly above the average estimate of $41.69 million [3] - Segment operating income for Physician and leadership solutions was $18.13 million, below the estimated $21.66 million [3] Stock Performance - AMN Healthcare shares have returned +5.2% over the past month, outperforming the Zacks S&P 500 composite's +3.2% change [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]